JAMES KEBLESH: Open Payments
NPI 1740620780 · TUCSON, AZ. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$178 in 10 payments from 5 companies in 2025. Trend: 2023 $0 · 2024 $19 · 2025 $178
Food & beverage: $178
| Company | Payments | Amount |
|---|---|---|
| Alkermes, Inc. | 4 | $73 |
| Otsuka America Pharmaceutical, Inc. | 2 | $35 |
| E.R. Squibb & Sons, L.L.C. | 2 | $32 |
| Teva Pharmaceuticals USA, Inc. | 1 | $21 |
| ABBVIE INC. | 1 | $18 |
Products named: ARISTADA, ABILIFY MAINTENA, COBENFY, UZEDY, VRAYLAR, LYBALVI, VIVITROL.
Industry payments across AZ — which companies pay providers there.
